threadlock7
I only post when I have a certificate to attach.
19kreputation
54answers
6accepted
31questions
0·2·8badges g·s·b
66tags
105What is the reported incidence of early satiety on tirzepatide in SURPASS-2?accepted · answered 3 Dec 2024 · gi-side-effects, clinical-trials, tirzepatide101How does cagrilintide behave on a C8 column compared to tirzepatide?answered 17 Jun 2024 · hplc, purity, reference-standard79How does orforglipron behave on a C18 column compared to survodutide?answered 22 Mar 2025 · hplc, purity, reference-standard79Is SELECT a fair comparison of a GLP-1 receptor agonist against its comparator arm?accepted · answered 22 Mar 2025 · clinical-trials, semaglutide, tirzepatide66Why does the same chromatogram give a different purity at 214 nm and at 280 nm?accepted · answered 26 Sept 2024 · hplc, purity, coa48How comparable are a GLP-1 receptor agonist and tirzepatide on the evidence available?answered 1 Aug 2024 · clinical-trials, semaglutide, tirzepatide48What should be in place before a first survodutide vial arrives from Qingdao?accepted · answered 16 Dec 2024 · harm-reduction, research-use-only, sterility44What is the reported incidence of vomiting on tirzepatide in SURPASS-3?answered 5 Oct 2025 · vomiting, clinical-trials, tirzepatide43What does 97.1% purity on a C4 column actually tell me about an orforglipron vial?answered 19 Oct 2025 · hplc, purity, coa41Is SURMOUNT-5 a fair head-to-head comparison?answered 17 Apr 2025 · tirzepatide, semaglutide, clinical-trials40Is there any published stability data for ecnoglutide at 37 °C?answered 13 Oct 2025 · peptide-stability, storage, clinical-trials35How comparable are mazdutide and retatrutide on the evidence available?answered 17 Apr 2026 · clinical-trials, semaglutide, tirzepatide35How comparable are oral semaglutide and liraglutide on the evidence available?answered 4 Jul 2025 · clinical-trials, semaglutide, tirzepatide32Would a sterility test distinguish dimerisation from a synthesis impurity in tirzepatide?answered 14 Feb 2025 · peptide-mapping, purity, mass-spec31Can I reconstitute cagrilintide at 10 mg/mL and still measure a small dose accurately?answered 14 Sept 2025 · diluent-volume, insulin-syringe, dosing-math29Does nausea at week six of survodutide usually resolve without a dose change?answered 21 Jun 2024 · nausea, titration, survodutide28Does reflux at week twelve of tirzepatide usually resolve without a dose change?answered 23 Dec 2024 · gi-side-effects, titration, tirzepatide28Is eGFR a better monitoring choice than HbA1c on tirzepatide?accepted · answered 8 Oct 2025 · bloodwork, kidney-function, lipids28What counter-ion should I expect on a QYB ecnoglutide lot?answered 10 Dec 2024 · acetate-content, purity, content-assay27How comparable are oral semaglutide and retatrutide on the evidence available?answered 22 Mar 2026 · clinical-trials, semaglutide, tirzepatide27If the mass spec matches exactly, why is that not proof the vial is pure?answered 25 Jan 2025 · mass-spec, purity, coa26How comparable are dulaglutide and cagrilintide on the evidence available?answered 4 Feb 2025 · clinical-trials, semaglutide, tirzepatide26How does liraglutide behave on a wide-pore C18 column compared to survodutide?answered 21 Nov 2024 · hplc, purity, reference-standard26Is an 18G drawing needle the right choice for drawing survodutide at 5 mg/mL?answered 11 Nov 2024 · needle-gauge, injection-technique, dead-space25Is STEP 4 a fair comparison of a GLP-1 receptor agonist against its comparator arm?answered 2 Feb 2025 · clinical-trials, semaglutide, tirzepatide25What is the reported incidence of early satiety on tirzepatide in SURMOUNT-2?answered 23 Aug 2024 · gi-side-effects, clinical-trials, tirzepatide23How comparable are orforglipron and retatrutide on the evidence available?answered 2 Dec 2025 · clinical-trials, semaglutide, tirzepatide22How long does survodutide stay within specification at room temperature once reconstituted?answered 1 Aug 2024 · peptide-stability, storage, shelf-life22Is SURMOUNT-5 a fair comparison of tirzepatide against its comparator arm?answered 20 Feb 2025 · clinical-trials, semaglutide, tirzepatide20Has anyone independently verified an MKM survodutide batch COA?answered 30 Jun 2024 · vendor-vetting, coa, batch-testing20Is GGT a better monitoring choice than albumin-to-creatinine ratio on retatrutide?answered 6 May 2024 · bloodwork, kidney-function, lipids19Does nausea at week ten of retatrutide usually resolve without a dose change?answered 1 Nov 2025 · nausea, titration, retatrutide19How comparable are retatrutide and cagrilintide on the evidence available?answered 7 Jun 2025 · clinical-trials, semaglutide, tirzepatide18Is GIP agonism or antagonism the metabolically useful direction?answered 18 Feb 2026 · gip-receptor, tirzepatide, glp1-mechanism18What is the reported incidence of nausea on tirzepatide in SURMOUNT-1?answered 23 Sept 2024 · nausea, clinical-trials, tirzepatide15Is there any published stability data for survodutide at 37 °C?answered 9 Jan 2025 · peptide-stability, storage, clinical-trials14Has anyone independently verified a GGPeps survodutide batch COA?answered 11 Mar 2025 · vendor-vetting, coa, batch-testing13Is resistance training ten times a week enough at 1,000 kcal a day?answered 24 Aug 2025 · resistance-training, lean-mass, exercise13What is the reported incidence of fatigue on retatrutide in TRIUMPH-1?answered 16 Nov 2024 · fatigue, clinical-trials, retatrutide12How many freeze-thaw cycles will survodutide at 8 mg/mL tolerate?answered 23 Jul 2026 · freeze-thaw, peptide-stability, storage8Is a 31G needle the right choice for drawing survodutide at 5 mg/mL?answered 3 Jul 2026 · needle-gauge, injection-technique, dead-space8What is the reported incidence of dizziness on tirzepatide in SURPASS-3?accepted · answered 25 Feb 2026 · clinical-trials, harm-reduction, tirzepatide7Why is the missed-dose window five days for one weekly agent and four for another?answered 17 Dec 2024 · missed-dose, semaglutide, tirzepatide5How comparable are retatrutide and survodutide on the evidence available?answered 21 Feb 2026 · clinical-trials, semaglutide, tirzepatide5Is early satiety on tirzepatide dose-dependent or dose-rate dependent?answered 28 Apr 2026 · gi-side-effects, titration, tirzepatide3Is 5 mg in 0.5 mL of bacteriostatic water a sensible presentation for tirzepatide?answered 17 Oct 2024 · diluent-volume, reconstitution, dosing-math2How many vials from a GGPeps lot should I send for a residual-solvent screen?answered 24 Jun 2024 · batch-testing, coa, cost-analysis2Is STEP 3 a fair comparison of a GLP-1 receptor agonist against its comparator arm?answered 26 Jul 2025 · clinical-trials, semaglutide, tirzepatide2What happens to survodutide after four weeks at 4 °C in solution?answered 7 May 2026 · peptide-stability, storage, shelf-life2What should be in place before a first orforglipron vial arrives from Qingdao?answered 18 Mar 2025 · harm-reduction, research-use-only, sterility1Does dizziness at week twelve of tirzepatide usually resolve without a dose change?answered 30 Apr 2025 · titration, harm-reduction, tirzepatide-2Does HbA1c tell me anything about hepatic fat on tirzepatide?answered 14 Jan 2025 · liver-enzymes, mash, bloodwork-2Is a domestic freezer good enough for storing reconstituted a GLP-1 receptor agonist?answered 28 May 2025 · storage, cold-chain, harm-reduction-3My cagrilintide vial sat at 40 °C for seven days — is testing worth it before use?answered 2 Jul 2025 · cold-chain, peptide-stability, batch-testing